Notify me when SR ONE CAPITAL MANAGEMENT, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Common Stock, $0.0001 par value | 9.4% | $111,851,442 | 5,037,854 | SR One Capital Management, LLC | 09 Oct 2025 | ||
| ORIC | ORIC Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 4.8% | $47,353,840 | 4,615,384 | 0% | SR One Capital Management, LLC | 12 Aug 2025 | |
| KALA | KALA BIO, Inc. | Common Stock, $0.001 par value | 4.6% | $5,255,568 | -$1,020,402 | 344,176 | -16% | SR One Capital Management, LLC | 14 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|